Recent results from large trials suggest that a target below 7% may be excessive: Below 7% the health benefits of reduced A1C become smaller, and the intensive glycemic control required to reach this level leads to an increased rate of dangerous hypoglycemic episodes.[20] A retrospective study of 47,970 diabetes patients found that patients with an A1C greater than 6.5% had an increased mortality rate.[21]